This page is not the official website. Generated by AI, does not constitute any advice. If needed, please click here to visit the corresponding official website.

Tianyuan
Pharmaceutical

A leading manufacturer and supplier of high-purity Active Pharmaceutical Ingredients (APIs) and Intermediates, specializing in targeted anticancer therapies and innovative drug development.

About Tianyuan

Shenzhen Tianyuan Pharmaceutical Technology Co., Ltd. is a specialized manufacturer focused on targeted anticancer drug research, dedicated to the development, production, and global marketing of high-quality medical raw materials.

With a strong commitment to innovation and quality, Tianyuan Pharmaceutical has established itself as a trusted partner in the pharmaceutical supply chain, delivering reliable APIs and intermediates to clients worldwide.

Specialized in oncology-targeted APIs
Global distribution network
Strict quality control & compliance
Tianyuan Pharmaceutical Facility

Our Products

High-purity APIs, Intermediates, and Specialty Compounds for Oncology and Chronic Disease Therapies

Regorafenib

Regorafenib

Multikinase inhibitor used in colorectal cancer, GIST, and hepatocellular carcinoma.

Polymyxin B Sulphate

Polymyxin B Sulphate

Antibiotic used for Gram-negative bacterial infections, especially in topical and ophthalmic formulations.

Fusidic Acid

Fusidic Acid

Steroid antibiotic effective against Gram-positive bacteria, used in skin and systemic infections.

Acalabrutinib

Acalabrutinib

Next-generation BTK inhibitor for the treatment of chronic lymphocytic leukemia (CLL).

Tucatinib

Tucatinib

Selective HER2 kinase inhibitor used in metastatic breast cancer with brain metastases.

Upadacitinib

Upadacitinib Hemihydrate

JAK1-selective inhibitor for rheumatoid arthritis and inflammatory conditions.

Deucravacitinib

Deucravacitinib

TYK2 inhibitor for psoriasis and autoimmune disorders.

Filgotinib

Filgotinib

Selective JAK1 inhibitor developed for inflammatory bowel disease and rheumatoid arthritis.

Crizotinib

Crizotinib

ALK and ROS1 inhibitor for non-small cell lung cancer (NSCLC).

Afatinib

Afatinib

Irreversible EGFR and HER2 inhibitor for NSCLC with specific mutations.

Olaparib

Olaparib

PARP inhibitor used in BRCA-mutated ovarian and breast cancers.

Lenvatinib

Lenvatinib

Multikinase inhibitor for thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma.

Research & Innovation

At Tianyuan Pharmaceutical, innovation drives everything we do. Our R&D team is committed to advancing targeted therapies in oncology and chronic diseases through cutting-edge chemistry and process optimization.

100+

APIs & Intermediates

In our portfolio, covering oncology, immunology, and infectious diseases.

15+

Years of Expertise

In pharmaceutical development and manufacturing excellence.

30+

Global Markets

Served with reliable supply and regulatory support.

Frequently Asked Questions

What types of products does Tianyuan Pharmaceutical manufacture?

We specialize in Active Pharmaceutical Ingredients (APIs), Intermediates, and specialty compounds, with a focus on targeted anticancer therapies such as kinase inhibitors and BTK inhibitors.

Are your products compliant with international standards?

Yes, our manufacturing processes follow strict quality control protocols, and we provide full documentation including CoA, DMF, and analytical reports to support regulatory submissions.

Can you provide custom synthesis services?

Yes, we offer custom synthesis and process development for APIs and intermediates. Contact us with your specific requirements.

How can I request a sample or quotation?

Please visit the official website or contact our sales team directly via email or phone for sample requests and pricing information.

Get in Touch

For inquiries, samples, or technical support, reach out to our team.

+86-13691738117
sales@tianpharm.com

Notice for Buyers: If you are a buyer, the above information is generated by AI collection and does not constitute any advice. If necessary, please visit the corresponding official website.

For Domain Owners: If you are the domain owner and do not want to be included by fobcompany.info, please contact support@fobcompany.info via your corporate email to cancel. We will cancel your inclusion within 3 business days.

如果您是域名所有者 不想被fobcompany.info收录 请用企业邮箱联系support@fobcompany.info 取消收录 我们将在3个工作日取消您的收录

Service Request: If you are other domain and want to be included, please contact support@fobcompany.info

如果您是其他域名合作 也请联系support@fobcompany.info